Dose Reduction for 89Zr ImmunoPET Imaging Using LAFOV PET/CT: An Analysis Based on Count-Reduced Images

被引:0
|
作者
Mohr, P. [1 ]
van Sluis, J. [1 ]
Providencia, L. [1 ]
Lammertsma, A. A. [1 ]
Brouwers, A. H. [1 ]
Tsoumpas, C. [1 ]
机构
[1] Univ Med Ctr Groningen, Groningen, Netherlands
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0124
引用
收藏
页码:S479 / S480
页数:2
相关论文
共 50 条
  • [31] First-time imaging of [89Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner
    Adrienne H. Brouwers
    Joyce van Sluis
    Johannes H. van Snick
    Carolina P. Schröder
    Inge O. Baas
    Ronald Boellaard
    Andor W. J. M. Glaudemans
    Ronald J. H. Borra
    Adriaan A. Lammertsma
    Rudi A. J. O. Dierckx
    Charalampos Tsoumpas
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3593 - 3595
  • [32] Optimization of 89Zr PET imaging using both phantom and clinical studies with [89Zr]-Df-IAB22M2C, an anti-CD8 minibody
    Daube-Witherspoon, Margaret
    Farwell, Michael
    Sunderland, John
    Viswanath, Varsha
    Korn, Ronald
    Wilson, Ian
    Karp, Joel
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [33] Histologically Confirmed Testicular Metastasis Revealed by [89Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging
    Rosar, Florian
    Burgard, Caroline
    Linxweiler, Johannes
    Wagner, Mathias
    Ezziddin, Samer
    DIAGNOSTICS, 2023, 13 (07)
  • [34] Acquisition and reconstruction protocol for [89Zr] Z-DFO-girentuzimab studies on BGO based PET/CT system
    Olivieri, M.
    Antunovic, L.
    Gelardi, F.
    Larcher, A.
    Sollini, M.
    Salonia, A.
    Chiti, A.
    Savi, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S336 - S336
  • [35] Immuno-PET Imaging of the GFR-2 Expression in Prostate Cancer Using 89Zr labeled Ramucirumab
    Li, Miao
    Chen, Weiyu
    Jiang, Dawei
    Engle, Jonathan
    Cao, Tianye
    Cai, Weibo
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [36] Synthesis and preclinical evaluation of 89Zr labeled Angiotensin peptide as a breast cancer imaging agent using PET.
    Okarvi, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S376 - S376
  • [37] Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT
    Walther, Martin
    Gebhardt, Peter
    Grosse-Gehling, Philipp
    Wuerbach, Lydia
    Irmler, Ingo
    Preusche, Stephan
    Khalid, Muhammad
    Opfermann, Thomas
    Kamradt, Thomas
    Steinbach, Joerg
    Saluz, Hans-Peter
    APPLIED RADIATION AND ISOTOPES, 2011, 69 (06) : 852 - 857
  • [38] Immuno PET imaging of CS1/SLAMF7 in multiple myeloma using 89Zr DFO elotuzumab
    Ghai, Anchal
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [39] 89Zr PET imaging guided validation of the medicinal potentiality of UiO-66 based nano drug delivery system
    Tan, Fuyuan
    Li, Wenliang
    Qiu, Long
    Lyu, Jie
    Peng, Haiyue
    Ding, Wenbing
    Liao, Jiali
    Yang, Yuanyou
    Liu, Ning
    Li, Feize
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2025, 334 (01) : 239 - 250
  • [40] Performance of nanoScan PET/CT and PET/MR for quantitative imaging of 18F and 89Zr as compared with ex vivo biodistribution in tumor-bearing mice
    Marion Chomet
    Maxime Schreurs
    Ricardo Vos
    Mariska Verlaan
    Esther J. Kooijman
    Alex J. Poot
    Ronald Boellaard
    Albert D. Windhorst
    Guus AMS van Dongen
    Danielle J. Vugts
    Marc C. Huisman
    Wissam Beaino
    EJNMMI Research, 11